Activation of the mTOR signaling pathway by L-leucine in 5q- syndrome and other RPS14-deficient erythroblasts.
Váldodahkkit: | Yip, B, Vuppusetty, C, Attwood, M, Giagounidis, A, Germing, U, Lamikanra, A, Roberts, D, Maciejewski, J, Vandenberghe, P, Mecucci, C, Wainscoat, J, Pellagatti, A, Boultwood, J |
---|---|
Materiálatiipa: | Journal article |
Giella: | English |
Almmustuhtton: |
2013
|
Geahča maid
-
Activation of the mTOR signaling pathway by L-leucine in 5q-syndrome and other RPS14-deficient erythroblasts
Dahkki: Yip, B, et al.
Almmustuhtton: (2013) -
Activation of the mTOR Signaling Pathway by L-Leucine in RPS14-Deficient Erythroid Cells
Dahkki: Yip, B, et al.
Almmustuhtton: (2012) -
Effects of L-leucine in 5q-syndrome and other RPS14-deficient erythroblasts
Dahkki: Yip, B, et al.
Almmustuhtton: (2012) -
Effects of L-leucine in 5q- syndrome and other RPS14-deficient erythroblasts.
Dahkki: Yip, B, et al.
Almmustuhtton: (2012) -
Activation of the mTOR pathway by the amino acid (L)-leucine in the 5q- syndrome and other ribosomopathies.
Dahkki: Boultwood, J, et al.
Almmustuhtton: (2013)